Delivery Order SPE2DR25D1103-SPE2DR26FD666
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,022.80 to AmerisourceBergen Drug Corp for the supply of Lantus SoloStar 100 Unit/ML 3ML insulin pens. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded on May 30, 2025, with an ultimate completion date of June 2, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under...
- The Defense Logistics Agency awarded a $5,369.70 delivery order to AmerisourceBergen Drug Corp for Lantus SoloStar 100 Unit/ML insulin pens on September 15, 2025, with completion expected by September 16, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award to the pharmaceutical distributor's corporate office located in Conshohocken, Pennsylvania. The contract reflects AmerisourceBergen's role as a critical federal vendor for military and veteran healthcare...
- The Defense Logistics Agency awarded a delivery order valued at $1,201.44 to AmerisourceBergen Drug Corp for Lantus SoloStar 100 Unit/mL insulin pens (3mL) on October 29, 2025, with an ultimate completion date of October 30, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, the company's corporate headquarters and primary distribution hub for federal...
- The Defense Logistics Agency awarded a delivery order valued at $8,800.02 to AmerisourceBergen Drug Corp for Lantus SoloStar 100 Unit/mL insulin pens on September 8, 2025, with an ultimate completion date of September 9, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a single delivery order under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,227.36 to AmerisourceBergen Drug Corp for Lantus SoloStar 100 Unit/mL 3mL insulin pens, with an ultimate completion date of August 29, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a single delivery order fulfillment. The place of performance is listed as Conshohocken, Pennsylvania, which serves as AmerisourceBergen's corporate headquarters and primary pharmaceutical...
- The Defense Logistics Agency awarded a $1,534.20 delivery order to AmerisourceBergen Drug Corp for Lantus SoloStar 100 Unit/mL 3mL insulin pens on September 22, 2025, with a completion date of September 23, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger indefinite delivery...
- The Defense Logistics Agency awarded a $2,348.65 delivery order to AmerisourceBergen Drug Corp for Lantus SoloStar 100 Unit/mL 3mL insulin pens, with an ultimate completion date of June 20, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,274.88 to AmerisourceBergen Drug Corp for Lantus SoloStar 100 Unit/ML insulin pens on October 29, 2025, with an ultimate completion date of October 30, 2025. This competitively awarded, non-set-aside contract employs firm fixed price terms and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract action under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $2,045.86 delivery order to AmerisourceBergen Drug Corp for Lantus SoloStar 100 Unit/mL 3mL insulin pens on September 24, 2025, with an ultimate completion date of September 25, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger federal contract vehicle. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,022.80 to AmerisourceBergen Drug Corp on March 12, 2025, for the supply of Lantus SoloStar 100 unit/mL 3mL insulin pens. This firm fixed-price delivery order represents a non-competitive, non-set-aside award and is scheduled for completion by March 13, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains its primary operations as a leading pharmaceutical...
- SPE2DR25D1103Indefinite Delivery Contract
- SPE2DR25D1103-SPE2DR26FD666Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,662.62 to supply Lantus SoloStar 100 Unit/ML 3ML insulin pens. This competitively awarded, non-set-aside contract was executed on October 28, 2025, with an ultimate completion date of October 29, 2025, and is classified as a firm fixed-price delivery order. The product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen's corporate office is headquartered. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This comprehensive vehicle enables the company to supply a broad range of pharmaceuticals and medical supplies to support military healthcare programs globally, including serving the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The contract reflects AmerisourceBergen's established role as a critical pharmaceutical distributor for federal medical procurement, particularly within the Defense Logistics Agency's supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 10/28/25 |